Literature DB >> 18602490

Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.

H Singha1, A I Mallick, C Jana, D P Isore, T K Goswami, S K Srivastava, V A Azevedo, P Chaudhuri, M Owais.   

Abstract

In the present study, we evaluated prophylactic prospective of liposome based DNA vaccine co-expressing Cu-Zn superoxide dismutase (SOD) along with interleukin-18 (IL-18) against experimental murine brucellosis. The immunization schedule involves liposome-mediated delivery of pVsod (encoding SOD of Brucella abortus) and pVIL18-sod (encoding IL-18 of mouse and SOD of B. abortus) DNA constructs. The data highlight potential of Escherichia coli lipid liposome (escheriosome) based DNA delivery vehicle to induce SOD specific humoral and cellular immune responses in the immunized mice. The co-expression of SOD along with IL-18 ensued in higher lymphoproliferative response and IFN-gamma production in comparison to the group of animals that were immunized with free form of SOD-DNA. Antibody response developed upon immunization with both DNA vaccines was of IgG2a type mainly. The results of the present study show that co-expression of IL-18 along with SOD polarized the antigen specific immune responses toward Th-1 direction, a desirable feature to control intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602490     DOI: 10.1016/j.micinf.2008.05.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

Review 1.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

2.  Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.

Authors:  Nicola J Commander; James M Brewer; Brendan W Wren; Stephen A Spencer; Alastair P Macmillan; Judith A Stack
Journal:  Genet Vaccines Ther       Date:  2010-07-16

3.  Co-immunization of plasmid DNA encoding IL-12 and IL-18 with Bacillus Calmette-Guérin vaccine against progressive tuberculosis.

Authors:  Bo-Young Jeon; Hyungjin Eoh; Sang-Jun Ha; Hyeeun Bang; Seung-Cheol Kim; Young-Chul Sung; Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

4.  Meta-Analysis and Advancement of Brucellosis Vaccinology.

Authors:  Tatiane F Carvalho; João Paulo A Haddad; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.

Authors:  Morteza Abkar; Mahdi Fasihi-Ramandi; Hamid Kooshki; Abbas Sahebghadam Lotfi
Journal:  Int J Nanomedicine       Date:  2017-12-13

6.  Immune Response and Protective Efficacy of a Heterologous DNA-Protein Immunization with Leishmania Superoxide Dismutase B1.

Authors:  Abebe Genetu Bayih; Nada S Daifalla; Lashitew Gedamu
Journal:  Biomed Res Int       Date:  2017-11-22       Impact factor: 3.411

7.  Efficient Immunization of BALB/c Mice against Pathogenic Brucella melitensis and B. ovis: Comparing Cell-Mediated and Protective Immune Responses Elicited by pCDNA3.1 and pVAX1 DNA Vaccines Coding for Omp31 of Brucella melitensis.

Authors:  Naser Harzandi; Haniyeh Aghababa; Nima Khoramabadi; Termeh Tabaraie
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

8.  Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

Authors:  Dinesh Kumar; Deepak Sharma; Gurmeet Singh; Mankaran Singh; Mahendra Singh Rathore
Journal:  ISRN Pharm       Date:  2012-07-19

9.  Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.

Authors:  Anthony P Cannella; Renee M Tsolis; Li Liang; Philip L Felgner; Mayuko Saito; Alessandro Sette; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Front Cell Infect Microbiol       Date:  2012-02-01       Impact factor: 5.293

Review 10.  A history of the development of Brucella vaccines.

Authors:  Eric Daniel Avila-Calderón; Ahidé Lopez-Merino; Nammalwar Sriranganathan; Stephen M Boyle; Araceli Contreras-Rodríguez
Journal:  Biomed Res Int       Date:  2013-06-03       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.